Meckel`s Extraordinary Complication
نویسندگان
چکیده
منابع مشابه
Meckels diverticulum and intestinal ischaemia
We report an exceptional case of intestinal ischaemia requiring resection, secondary to torsion around a long Meckel's diverticulum. Meckel's diverticulum is an uncommon congenital abnormality of the small bowel. Meckel's diverticulum giving rise to intestinal ischaemia that requires resection is very rare but potentially fatal complication. A 62 year old woman presented as an emergency with su...
متن کاملManagement of asymptomatic or incidental Meckels diverticulum.
This study was conducted to compare the clinicopathologic characteristics of incidentally found and symptomatic cases of Meckels diverticulum with the aim of arriving at a recommendation regarding the management of incidental cases. A retrospective chart review was performed over a period of 24 years. Incidental group had 52 patients and symptomatic group had 128 patients(71%). Obstruction (42....
متن کاملMeckels Diverticulum Causing Volvulus of Ileum
The most common complications of Meckel’s diverticulum are Intestinal obstruction, gastrointestinal haemorrhage, adherence, intussusception, acute diverticulitis and rarely malignancy. Reported mechanism of intestinal obstruction in Meckel’s diverticulum include invagination, adherence and volvulus. Obstruction of ileum caused by volvulus of Meckel’s diverticulum is not a very frequent conditio...
متن کاملExtraordinary claims require extraordinary evidence.
At the beginning of 2003, the Journal of Health Economics published a paper of great importance in public policy by DiMasi, Hansen, and Grabowski (referred to hereafter as “DHG 2003”). The paper is based primarily on confidential, proprietary data supplied by pharmaceutical companies to the Tufts Center for the Study of Drug Development, a research center that receives significant unrestricted ...
متن کاملExtraordinary claims require extraordinary evidence
We thank Light and Warburton (2005) [hereafter LW] for providing a context for us to further discuss and clarify our studies on the cost of new drug development (DiMasi et al., 2003 [hereafter DHG]; DiMasi et al., 1991b [hereafter DHGL]; Hansen, 1979). We disagree, however, with their analyses, comparators, and conclusions. Although LW suggest, through the invocation of selected reported cost f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Balkan Medical Journal
سال: 2020
ISSN: 2146-3123,2146-3131
DOI: 10.4274/balkanmedj.galenos.2020.2019.11.23